Chemoinformaics analysis of 4a, 5,6,7,7a-hexahydrocyclopetan pyran-4,7-dicaroxylate
| Molecular Weight | 150.221 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 11 |
| Exact Molecular Weight | 150.104 | nRing | 2 |
| Solubility: LogS | -2.451 | nHRing | 1 |
| Solubility: LogP | 2.886 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.52 |
| Synth | 4.555 |
| Natural Product Likeliness | 2.176 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.041 |
| HIA | 0.01 |
| CACO-2 | -4.37 |
| MDCK | 0.0000302 |
| BBB | 0.475 |
| PPB | 0.818972 |
| VDSS | 1.446 |
| FU | 0.167799 |
| CYP1A2-inh | 0.452 |
| CYP1A2-sub | 0.725 |
| CYP2c19-inh | 0.111 |
| CYP2c19-sub | 0.787 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.107 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.724 |
| CYP3a4-inh | 0.451 |
| CYP3a4-sub | 0.283 |
| CL | 2.372 |
| T12 | 0.476 |
| hERG | 0.02 |
| Ames | 0.091 |
| ROA | 0.659 |
| SkinSen | 0.571 |
| Carcinogencity | 0.263 |
| EI | 0.993 |
| Respiratory | 0.178 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.93719 |